- Titre
- Off-label use of prasugrel in stable coronary artery disease is associated with greater degree of platelet inhibition compared with use after acute coronary syndrome
- Créateurs - sans rôle
- Thomas Cuisset - CHU Timone, Dept Cardiol, F-13385 Marseille, FranceGuillaume Cayla - Univ Montpellier I, Serv Cardiol, CHU Nimes, F-34006 Montpellier, FranceJacques Quilici - CHU Timone, Dept Cardiol, F-13385 Marseille, FranceMathieu Pankert - CHU Timone, Dept Cardiol, F-13385 Marseille, FrancePierre Deharo - CHU Timone, Dept Cardiol, F-13385 Marseille, FranceGuillaume Bonnet - CHU Timone, Dept Cardiol, F-13385 Marseille, FranceCharlotte Grosdidier - INSERM, UMR1062, F-13385 Marseille, FranceShirley Beguin - Assistance Publ Hop Marseille, EMAI, Marseille, FrancePierre Morange - INSERM, UMR1062, F-13385 Marseille, FranceJean-Louis Bonnet - CHU Timone, Dept Cardiol, F-13385 Marseille, FranceMarie-Christine Alessi - INSERM, UMR1062, F-13385 Marseille, France
- Détails de publication
- International journal of cardiology, Vol.168(3), pp.2988-2989
- Éditeur
- Elsevier
- Nombre de pages
- 3
- Identifiants
- 99148927909311
- Unité académique
- Recherche hors université
- Langue
- English
- Type de ressource
- Journal article
Article de revue
Off-label use of prasugrel in stable coronary artery disease is associated with greater degree of platelet inhibition compared with use after acute coronary syndrome
International journal of cardiology, Vol.168(3), pp.2988-2989
03/10/2013
PMID: 23642612
Indicateurs
1 Consultations de la notice